{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:30:56Z","timestamp":1785767456500,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","burnsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.burns.2015.12.001","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T16:10:26Z","timestamp":1453219826000},"page":"830-835","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Burn unit care of Stevens Johnson syndrome\/toxic epidermal necrolysis: A survey"],"prefix":"10.1016","volume":"42","author":[{"given":"Hong-Gam","family":"Le","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajirah","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iason S.","family":"Mantagos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Goverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Chodosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.burns.2015.12.001_bib0225","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","article-title":"Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis","volume":"333","author":"Roujeau","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.burns.2015.12.001_bib0230","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1081-1206(10)61112-X","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature","volume":"94","author":"Letko","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.burns.2015.12.001_bib0235","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0240","doi-asserted-by":"crossref","first-page":"187.e1","DOI":"10.1016\/j.jaad.2013.05.002","article-title":"Toxic epidermal necrolysis: Part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0245","doi-asserted-by":"crossref","first-page":"173.e1","DOI":"10.1016\/j.jaad.2013.05.003","article-title":"Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis","volume":"69","author":"Schwartz","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0250","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.autrev.2008.06.004","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"7","author":"Borchers","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.burns.2015.12.001_bib0255","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2133.1996.tb03598.x","article-title":"Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"135","author":"Rzany","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0260","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/archderm.1990.01670250043005","article-title":"Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981\u20131985","volume":"126","author":"Roujeau","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0265","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archderm.1990.01670250049006","article-title":"The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients","volume":"126","author":"Chan","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0270","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1001\/archderm.1990.01670320127028","article-title":"Incidence of toxic epidermal necrolysis in Italy","volume":"126","author":"Naldi","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0275","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/sim.4780100408","article-title":"Using a claims database to investigate drug-induced Stevens-Johnson syndrome","volume":"10","author":"Strom","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/j.burns.2015.12.001_bib0280","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000247299","article-title":"Evolving pattern of drug-induced toxic epidermal necrolysis","volume":"186","author":"Correia","year":"1993","journal-title":"Dermatology"},{"key":"10.1016\/j.burns.2015.12.001_bib0285","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0895-4356(96)00035-2","article-title":"Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry","volume":"49","author":"Rzany","year":"1996","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.burns.2015.12.001_bib0290","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.burns.2015.12.001_bib0295","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/BCR.0b013e31815f3658","article-title":"Treatment strategies in toxic epidermal necrolysis syndrome: where are we at?","volume":"29","author":"Abood","year":"2008","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2015.12.001_bib0300","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2133.2005.06721.x","article-title":"Toxic epidermal necrolysis: current evidence, practical management and future directions","volume":"153","author":"Chave","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0305","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1346-8138.1998.tb02450.x","article-title":"Toxic epidermal necrolysis with severe gastrointestinal mucosal cell death: a patient who excreted long tubes of dead intestinal epithelium","volume":"25","author":"Sugimoto","year":"1998","journal-title":"J Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0310","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/archderm.1987.01660330071012","article-title":"Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0315","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archderm.1987.01660330067010","article-title":"Treatment of toxic epidermal necrolysis. Creteil's experience","volume":"123","author":"Revuz","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0320","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0733-8635(05)70196-0","article-title":"Toxic epidermal necrolysis","volume":"18","author":"Wolkenstein","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.burns.2015.12.001_bib0325","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2230.2010.03826.x","article-title":"Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre","volume":"35","author":"Rajaratnam","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0330","article-title":"Complications of Stevens-Johnson syndrome beyond the eye and skin","author":"Saeed","year":"2015","journal-title":"Burns"},{"key":"10.1016\/j.burns.2015.12.001_bib0335","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICO.0b013e31802eb264","article-title":"Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management","volume":"26","author":"Chang","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.burns.2015.12.001_bib0340","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1001\/archdermatol.2009.293","article-title":"The management of severe ocular complications of stevens-johnson syndrome and toxic epidermal necrolysis","volume":"145","author":"Sotozono","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0345","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ophtha.2008.12.048","article-title":"Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications","volume":"116","author":"Sotozono","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.burns.2015.12.001_bib0350","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1172-5-39","article-title":"Toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"5","author":"Harr","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.burns.2015.12.001_bib0355","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000070938","article-title":"Dermatological and ophthalmological sequels in toxic epidermal necrolysis","volume":"207","author":"Magina","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.burns.2015.12.001_bib0360","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/peds.109.1.74","article-title":"Long-term consequences of toxic epidermal necrolysis in children","volume":"109","author":"Sheridan","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.burns.2015.12.001_bib0365","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/01.bcr.0000194268.01514.f8","article-title":"Long-term follow-up of patients treated for toxic epidermal necrolysis","volume":"27","author":"Oplatek","year":"2006","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2015.12.001_bib0370","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1097\/BCR.0b013e3181848bb1","article-title":"Toxic epidermal necrolysis clinical guidelines","volume":"29","author":"Endorf","year":"2008","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2015.12.001_bib0375","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1440-0960.2011.00862.x","article-title":"The management of toxic epidermal necrolysis","volume":"53","author":"Fernando","year":"2012","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0380","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/1060028014560012","article-title":"Corticosteroids in Stevens-Johnson Syndrome\/toxic epidermal necrolysis: current evidence and implications for future research","volume":"49","author":"Law","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.burns.2015.12.001_bib0385","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","article-title":"The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis","volume":"167","author":"Huang","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0390","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1365-2133.1996.tb01167.x","article-title":"Recombinant granulocyte colony-stimulating factor in the management of toxic epidermal necrolysis","volume":"135","author":"Goulden","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0395","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5603\/AIT.2015.0037","article-title":"Toxic epidermal necrolysis","volume":"47","author":"Hinc-Kasprzyk","year":"2015","journal-title":"Anaesthesiol Intensive Ther"},{"key":"10.1016\/j.burns.2015.12.001_bib0400","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.jid.5700068","article-title":"Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis","volume":"126","author":"Guegan","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0405","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0029-7844(97)00596-6","article-title":"Vulvovaginal involvement in toxic epidermal necrolysis: a retrospective study of 40 cases","volume":"91","author":"Meneux","year":"1998","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.burns.2015.12.001_bib0410","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/01.BCR.0000150215.78220.79","article-title":"Late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a burn center","volume":"26","author":"Haber","year":"2005","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.burns.2015.12.001_bib0415","first-page":"153","article-title":"Vulvovaginal sequelae in toxic epidermal necrolysis","volume":"42","author":"Meneux","year":"1997","journal-title":"J Reprod Med"},{"key":"10.1016\/j.burns.2015.12.001_bib0420","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/j.1365-4632.2007.03277.x","article-title":"Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome","volume":"46","author":"Fromowitz","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.burns.2015.12.001_bib0425","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1007\/s001340051063","article-title":"Lack of significant treatment effect of plasma exchange in the treatment of drug-induced toxic epidermal necrolysis","volume":"25","author":"Furubacke","year":"1999","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.burns.2015.12.001_bib0430","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/pgmj.2007.061465","article-title":"Management of toxic epidermal necrolysis and related syndromes","volume":"84","author":"Mukasa","year":"2008","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.burns.2015.12.001_bib0435","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S1542-0124(12)70273-2","article-title":"The ophthalmologic management of acute Stevens-Johnson syndrome","volume":"6","author":"Gregory","year":"2008","journal-title":"Ocul Surf"},{"key":"10.1016\/j.burns.2015.12.001_bib0440","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jaad.2006.04.048","article-title":"Toxic epidermal necrolysis","volume":"56","author":"Pereira","year":"2007","journal-title":"J Am Acad Dermatol"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417915003915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417915003915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T03:53:35Z","timestamp":1537070015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417915003915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0305417915003915"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2015.12.001","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burn unit care of Stevens Johnson syndrome\/toxic epidermal necrolysis: A survey","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2015.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}